eCQM for the 2022 Performance Period

Percentage of the following patients - all considered at high risk of cardiovascular events - who were prescribed or were on statin therapy during the measurement period:

• All patients with an active diagnosis of clinical ASCVD or ever had an ASCVD procedure.
• Patients aged >= 20 years at the beginning of the measurement period who have ever had a laboratory result of LDL-cholesterol (LDL-C) >=190 mg/dL or were previously diagnosed with or currently have an active diagnosis of familial hypercholesterolemia.
• Patients aged 40 to 75 years at the beginning of the measurement period with type 1 or type 2 diabetes.

Additional information available here.